Schirrmacher, R.; Bailey, J.J.; Mossine, A.V.; Scott, P.J.H.; Kaiser, L.; Bartenstein, P.; Lindner, S.; Kaplan, D.R.; Kostikov, A.; Fricker, G.;
et al. Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging. Pharmaceuticals 2019, 12, 7.
https://doi.org/10.3390/ph12010007
AMA Style
Schirrmacher R, Bailey JJ, Mossine AV, Scott PJH, Kaiser L, Bartenstein P, Lindner S, Kaplan DR, Kostikov A, Fricker G,
et al. Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging. Pharmaceuticals. 2019; 12(1):7.
https://doi.org/10.3390/ph12010007
Chicago/Turabian Style
Schirrmacher, Ralf, Justin J. Bailey, Andrew V. Mossine, Peter J. H. Scott, Lena Kaiser, Peter Bartenstein, Simon Lindner, David R. Kaplan, Alexey Kostikov, Gert Fricker,
and et al. 2019. "Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging" Pharmaceuticals 12, no. 1: 7.
https://doi.org/10.3390/ph12010007
APA Style
Schirrmacher, R., Bailey, J. J., Mossine, A. V., Scott, P. J. H., Kaiser, L., Bartenstein, P., Lindner, S., Kaplan, D. R., Kostikov, A., Fricker, G., Mahringer, A., Rosa-Neto, P., Schirrmacher, E., Wängler, C., Wängler, B., Thiel, A., Soucy, J. -P., & Bernard-Gauthier, V.
(2019). Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging. Pharmaceuticals, 12(1), 7.
https://doi.org/10.3390/ph12010007